Predictions
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€6.65
10.12.20
10.12.20
€6.00
10.12.21
10.12.21
0.00%
22.12.20
22.12.20
Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
Inovio Pharma
Start price
Target price
Perf. (%)
€9.35
10.12.20
10.12.20
€7.00
10.12.21
10.12.21
20.86%
20.02.21
20.02.21
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
2G Energy AG
Start price
Target price
Perf. (%)
€84.40
10.12.20
10.12.20
€75.00
10.12.21
10.12.21
-0.71%
22.12.20
22.12.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Lexicon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.56
08.12.20
08.12.20
-
6.64%
10.12.20
10.12.20
Risky Investment
Amadeus FiRe AG
Start price
Target price
Perf. (%)
€121.80
07.12.20
07.12.20
€168.00
07.12.21
07.12.21
49.10%
08.12.21
08.12.21
Could be worthwhile Investment >10% per year
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.51
07.12.20
07.12.20
€25.00
07.12.21
07.12.21
93.92%
08.12.21
08.12.21
Could be very worthwhile Investment >20% year
Bertrandt AG
Start price
Target price
Perf. (%)
€41.55
05.12.20
05.12.20
€58.00
28.02.22
28.02.22
22.74%
23.01.22
23.01.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
Fair valuation
Trevena Inc.
Start price
Target price
Perf. (%)
€49.08
04.12.20
04.12.20
€55.00
28.04.21
28.04.21
23.84%
09.02.21
09.02.21
Could be very worthwhile Investment >20% year
Ferroglobe plc
Start price
Target price
Perf. (%)
€1.48
04.12.20
04.12.20
-
04.12.21
04.12.21
251.35%
05.12.21
05.12.21
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€3.58
04.12.20
04.12.20
-
04.12.21
04.12.21
282.12%
05.12.21
05.12.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Gaussin S.A.
Start price
Target price
Perf. (%)
€11.20
03.12.20
03.12.20
€18.00
03.12.21
03.12.21
-39.55%
05.08.21
05.08.21
Could be very worthwhile Investment >20% year
Undervalued
Hexagon Composites ASA
Start price
Target price
Perf. (%)
€5.80
02.12.20
02.12.20
-
02.12.21
02.12.21
-12.07%
23.02.21
23.02.21
Business model of the past or high risk
Higher risks for its business
iRhythm Technologies Inc
Start price
Target price
Perf. (%)
€151.00
02.12.20
02.12.20
-
02.12.21
02.12.21
-42.05%
03.12.21
03.12.21
Risky Investment
Cellcom Israel Ltd
Start price
Target price
Perf. (%)
€3.76
02.12.20
02.12.20
-
02.12.21
02.12.21
6.38%
03.12.21
03.12.21
Could be worthwhile Investment >10% per year
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€11.72
02.12.20
02.12.20
-
02.12.21
02.12.21
-39.70%
03.12.21
03.12.21
Could be worthwhile Investment >10% per year
Copper Mountain Mining Corp.
Start price
Target price
Perf. (%)
€1.02
02.12.20
02.12.20
-
02.12.21
02.12.21
138.24%
03.12.21
03.12.21
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€46.50
01.12.20
01.12.20
€90.00
01.12.21
01.12.21
-27.97%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€202.00
30.11.20
30.11.20
€400.00
30.11.21
30.11.21
1.98%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year